DS

Deepak Singh Bhadauria

Active Director Director DIN 11464921
DIN 11464921 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepak Singh Bhadauria

Data last updated:

Deepak Singh Bhadauria is a Director at Topchem Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11464921
Primary Designation Director
Industry Pharma
First Appointment 05 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 20262026Active

Board colleagues of Deepak Singh Bhadauria

Directorship timeline

Open interactive timeline →
Topchem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Deepak Singh Bhadauria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Singh Bhadauria

Deepak Singh Bhadauria currently holds 1 directorship: Topchem Pharmaceuticals Private Limited (Director, since 05 Jan 2026).

Deepak Singh Bhadauria was first appointed on 05 Jan 2026 as Director at Topchem Pharmaceuticals Private Limited.

The current boards of Deepak Singh Bhadauria's companies include Sadanand Yadav (Topchem Pharmaceuticals Private Limited), Shivdeep Chauhan (Topchem Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available